Manidipine: Difference between revisions
No edit summary |
No edit summary |
||
Line 30: | Line 30: | ||
__NOTOC__ | __NOTOC__ | ||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}}; {{SS}} | ||
==Overview== | ==Overview== |
Latest revision as of 20:22, 23 July 2014
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C35H38N4O6 |
Molar mass | 610.69 g/mol |
WikiDoc Resources for Manidipine |
Articles |
---|
Most recent articles on Manidipine |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Manidipine at Clinical Trials.gov Clinical Trials on Manidipine at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Manidipine
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Manidipine Discussion groups on Manidipine Patient Handouts on Manidipine Directions to Hospitals Treating Manidipine Risk calculators and risk factors for Manidipine
|
Healthcare Provider Resources |
Causes & Risk Factors for Manidipine |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Sheng Shi, M.D. [2]
Overview
Manidipine (INN) is a calcium channel blocker (dihydropyridine type) that is used clinically as an antihypertensive.[1][2][3][4][5]
References
- ↑ Cheer, S.M.; McClellan, K. (2001), "Manidipine: A Review of its Use in Hypertension", Drugs, 61 (12): 1777–99, doi:10.2165/00003495-200161120-00010, PMID 11693466, retrieved 2009-06-20
- ↑ McKeage, K.; Scott, L.J. (2004), "Manidipine: A Review of its Use in the Management of Hypertension", Drugs, 64 (17): 1923–40, doi:10.2165/00003495-200464170-00011, PMID 15329044, retrieved 2009-06-20
- ↑ Roca-cusachs, A.; Triposkiadis, F. (2005), "Antihypertensive Effect of Manidipine", Drugs, 65: 11–9, doi:10.2165/00003495-200565002-00003, PMID 16398058, retrieved 2009-06-20
- ↑ Otero, M.L. (2007), "Manidipine–delapril combination in the management of hypertension", Vascular Health and Risk Management, 3 (3): 255–63, PMC 2293964, PMID 17703633
- ↑ Mizuno, Kenji (August 1992), "Evaluation of manidipine hydrochloride, a new calcium antagonist, in the treatment of hypertensive patients with renal disorders", Current Therapeutic Research, 52 (2): 248–253, doi:10.1016/S0011-393X(05)80475-8, retrieved 2009-06-20 Unknown parameter
|coauthors=
ignored (help)
- Pages with script errors
- Pages with citations using unsupported parameters
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Calcium channel blockers
- Cardiovascular Drugs
- Drug